Maxim Group reaffirmed their buy rating on shares of Athersys, Inc. (NASDAQ:ATHX) in a report released on Sunday, AnalystRatingsNetwork.comreports. Maxim Group currently has a $5.00 price target on the biopharmaceutical company’s stock.
Athersys, Inc. (NASDAQ:ATHX) belongs to Healthcare sector. Its weekly performance is 8.75%. On last trading day company shares ended up at $1.74. Athersys, Inc. (NASDAQ:ATHX) distance from 50-day simple moving average (SMA50) is 5.52%.
On 26 February, Hilton Worldwide Holdings Inc. (NYSE:HLT) said that, it is lodging properties and timeshare business will be spun off into separate publicly traded companies, the company announced Friday.
Hilton Worldwide Holdings Inc. (NYSE:HLT) shares increased 2.48% in last trading session and ended the day at $20.70. HLT Gross Margin is 63.40% and its return on assets is 2.90%. Hilton Worldwide Holdings Inc. (NYSE:HLT) quarterly performance is -11.73%.
JinkoSolar Holding Co., Ltd. (NYSE:JKS) will release its Q415 earnings data on Tuesday, March 1st. Analysts expect JinkoSolar Holding Co. to post earnings of $1.27 per share and revenue of $712.87 million for the quarter.
On 26 February, JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares increased 3.11% and was closed at $23.55. JKS EPS growth in last 5 year was 51.30%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) year to date (YTD) performance is -14.89%.
On 23 February, Alcoa Inc. (NYSE:AA) said that, Deere & Co., headquartered in Moline, and Alcoa, with its Alcoa Davenport Works facility in Riverdale, both were selected in the annual ranking on corporate reputation. Deere ranked 46th on the world’s Top 50 Most Admired Companies list. The top five companies on the 2016 Most Admired list were Apple, Alphabet, Amazon, Berkshire Hathaway and Walt Disney.
Alcoa Inc. (NYSE:AA) ended the last trading day at $8.87. Company weekly volatility is calculated as 5.88% and price to cash ratio as 6.06. Alcoa Inc. (NYSE:AA) showed a weekly performance of 12.71%.
On 25 February, Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2015. Cash, cash equivalents and marketable securities as of December 31, 2015 were $289.9 million compared to $304.6 million as of September 30, 2015.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares increased 10.27% in last trading session and ended the day at $7.62. CLDX return on assets is -36.30%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -57.17%.